BioTech appointed Frank Bedu-Addo as CEO on September 2, 2025.
2 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioTech appointed Frank Bedu-Addo as CEO on September 2, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- PDS Biotechnology, led by Frank Bedu-Addo, appointed KPMG LLP as its independent registered public accounting firm.Sub-event
BioTech appoints Frank Bedu-Addo as CEO.1 source
Keep exploring
The entities involved
-
BioTech
company in Prague, Czechia
-
Frank Bedu-Addo
researcher
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswirePDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PRINCETON, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biote
- GlobeNewswirePDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update Multiple Abstracts Presented at the 2025 American Society of Clinical Oncology Annual Meeting Conferenc